Article Listing - ARES-SERONO1992 SALES UP 16.7%

INTERFERON ALFA-N3 AND AIDS

6 April 1992

Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...

GERMAN POLICY UNDER FIRE

6 April 1992

German Health Minister Gerda Hasselfeldt has accused the leading German doctors' organization, the Hartmannbund, of political agitation, after it held...

SANOFI 1991 NET INCOME UP 12.1%

6 April 1992

For France's Elf Sanofi, earnings progressed satisfactorily in 1991 despite the adverse operating environment (the world economic situation including the...

WORLD MARKET FOR BIO-DRUGS

6 April 1992

Biopharmaceuticals will be the single fastest-growing segment of the total pharmaceutical market worldwide in the 1990s, with average annual growth...

PFIZER'S DIFLUCAN

6 April 1992

Prophylactic administration of Pfizer's Diflucan (fluconazole) to recipients of autologous bone marrow transplants reduces the incidence of both systemic and...

ALLELIX BIOPHARMA: DOUGLAS FROOM

6 April 1992

Douglas Froom has been appointed as vice president for business development at Allelelix Biopharmaceuticals Inc, of Canada.

BIOSCIENCE/FUTURE MEDICAL DEAL

6 April 1992

Bioscience International has reached an agreement with Future Medical Products to begin testing of a product used to neutralize HIV....

EPIC REGISTRATION NOW OVER 1,300

6 April 1992

Speaking at the 12th International Symposium on Intensive Care and Emergency Medicine in Brussels, late last month, Andre Heyns, Roussel-...

EURO DRUGMAKERS STOCK "UNDERVALUED"

6 April 1992

Despite the enormous size of some Continental European pharmaceutical companies, they are being valued by their respective equity capital markets...

GLOBAL MARKETS AND FACTORS FOR SUCCESS

6 April 1992

As the geographical borders between pharmaceutical markets begin to disappear, so do the differences among the critical success factors for...

Showing 94651-94660 of 95569 articles